Food for thought : The need for strategic development of safety sciences

Altex

Volumn 34, Issue 1, 2017, Pages 3-21

  Busquet, Francois ^a   Hartung, Thomas ^a,b  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Alternative test methods; Regulatory toxicology; Scientific policy advice; Testing strategies

Indexed keywords

DRIVER; EUROPE; HUMAN; LAW; RISK ASSESSMENT; SCIENCE; THINKING; TOXICOLOGY; GOVERNMENT REGULATION; HEALTH CARE POLICY; INTERNATIONAL COOPERATION; LEGISLATION AND JURISPRUDENCE; MANAGEMENT; MEDICAL RESEARCH; ORGANIZATION AND MANAGEMENT; PROGRAM DEVELOPMENT; SAFETY; STANDARDS;

BIOMEDICAL RESEARCH; EUROPE; GOVERNMENT REGULATION; HEALTH POLICY; INTERNATIONAL COOPERATION; POLICY MAKING; PROGRAM DEVELOPMENT; RISK ASSESSMENT; SAFETY; TOXICOLOGY;

EID: 85012014885     PISSN: 1868596X     EISSN: 18688551     Source Type: Journal    
DOI: 10.14573/altex.1701031     Document Type: Article

References (69)

1. Alépée, N., Bahinski, T., Daneshian, M. et al. (2014). State-of-The-Art of 3D cultures (organs-on-A-chip) in safety testing and pathophysiology -A t4 report. ALTEX 31, 441-477. https://doi.org/10.14573/altex1406111.
2. Andersen, M. E., Clewell, H. J., Carmichael, P. L. and Boekelheide, K. (2011). Can case study approaches speed implementation of the NRC report: "Toxicity testing in the 21st century: A vision and a strategy?" ALTEX 28, 175-182. https://doi.org/10.14573/altex.2011.3.175.
3. Andersen, M. E., McMullen, P. D. and Krewski, D. (2015). Developing tools for defining and establishing pathways of toxicity. Arch Toxicol 89, 809-812. https://doi.org/10.1007/s00204-015-1512-y.
4. Ankley, G. T., Bennett, R. S., Erickson, R. J. et al. (2010). Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29, 730-741. https://doi.org/10.1002/etc.34.
5. Ankley, G., Escher, B., Hartung, T. and Shah, I. (2016). Pathway-based approaches for environmental monitoring and risk assessment. Environ Sci Technol 50, 10295-10296. https://doi.org/10.1021/acs.est.6b04425.
6. Ball, N., Cronin, M. T. D., Shen, J. et al. (2016). Toward good read-Across practice (GRAP) guidance. ALTEX 33, 149-166. https://doi.org/10.14573/altex.1601251.
7. Basketter, D. A., Clewell, H., Kimber, I. et al. (2012). A roadmap for the development of alternative (non-Animal) methods for systemic toxicity testing. ALTEX 29, 3-89. https://doi.org/10.14573/altex.2012.1.003.
8. Benfenati, E., Berggren, E., Fritsche, E. et al. (2016). Novel chemical hazard characterisation approaches. EFSA J 14, Spec Issue S1, s0506. https://doi.org/10.2903/j.efsa.2016.s0506.
9. Bottini, A. A., Alepee, N., De Silva, O. et al. (2008). Optimization of the post-validation process. The report and recommendations of ECVAM workshop 67. Altern Lab Anim 36, 353-366.
10. Bouhifd, M., Andersen, M. E., Baghdikian, C. et al (2015). The human toxome project. ALTEX 32, 112-124. https://doi.org/10.14573/altex.1502091.
11. Busquet, F., Zurlo, J. and Hartung, T. (2017). Trans-Atlantic harmonization of standards: What could be the benefits of TTIP with regards to laboratory animal welfare in safety testing and 3Rs. ILAR J, in press.
12. Callaway, E. (2012). Daily dose of toxics to be tracked. Nature 491, 647-647. https://doi.org/10.1038/491647a.
13. Coecke, S., Balls, M., Bowe, G. et al. (2005). Guidance on good cell culture practice. Altern Lab Anim 33, 261-287.
14. Coecke, S., Goldberg, A. M., Allen, S. et al. (2007). Incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies. Environ Health Perspect 115, 924-931. https://doi.org/10.1289/ehp.9427.
15. Daneshian, M., Kamp, H., Hengstler, J. et al. (2016). Highlight report: Launch of a large integrated European in vitro toxicology project: EU-ToxRisk. Arch Toxicol 90, 1021-1024. https://doi.org/10.1007/s00204-016-1698-7.
16. Demortain, D. (2011). Scientists and the Regulation of Risk. Standardising Control. Cheltenham, UK and Aldershot, MA, USA: Edward Elgar Publishing. https://doi.org/10.4337/9781849809443.
17. Embry, M. R., Bachman, A. N., Bell, D. R. et al. (2014). Risk assessment in the 21st century: Roadmap and matrix. Crit Rev Toxicol 44, Suppl 3, 6-16. https://doi.org/10.3109/10408444. 2014.931924.
18. Escher, B. I., Hackermüller, J., Polte, T. et al. (2016). From the exposome to mechanistic understanding of chemical-induced adverse effects. Environ Int, Epub ahead of print. https://doi.org/10.1016/j.envint.2016.11.029.
19. Fasani, R. A., Livi, C. B., Choudhury, D. R. et al. (2016). The human toxome collaboratorium: A shared environment for multi-omic computational collaboration within a consortium. Front Pharmacol 6, 322. https://doi.org/10.3389/fphar.2015.00322.
20. Gordon, S., Daneshian, M., Bouwstra, J. et al. (2015). Non-Animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicology. ALTEX 32, 327-378. https://doi.org/10.14573/altex.1510051.
21. Guzelian, P. S., Victoroff, M. S., Halmes, N. C. et al. (2005). Evidence-based toxicology: A comprehensive framework for causation. Hum Exp Toxicol 24, 161-201. https://doi.org/10.1191/0960327105ht517oa.
22. Hartung, T., Bremer, S., Casati, S. et al. (2004). Modular approach to the ECVAM principles on test validity. Altern Lab Anim 32, 467-472.
23. Hartung, T. (2008). Towards a new toxicology - evolution or revolution? Altern Lab Anim 36, 635-639.
24. Hartung, T. (2009a). Toxicology for the twenty-first century. Nature 460, 208-212. https://doi.org/10.1038/460208a.
25. Hartung, T. (2009b). A toxicology for the 21st century: Mapping the road ahead. Toxicol Sci 109, 18-23. https://doi.org/10.1093/toxsci/kfp059.
26. Hartung, T. (2010a). Evidence based-Toxicology -The toolbox of validation for the 21st century? ALTEX 27, 241-251. https://doi.org/10.14573/altex.2010.4.253.
27. Hartung, T. (2010b). Lessons learned from alternative methods and their validation for a new toxicology in the 21st century. J Toxicol Env Health 13, 277-290. https://doi.org/10.1080/10937404.2010.483945.
28. Hartung, T. (2010c). Comparative analysis of the revised Directive 2010/63/EU for the protection of laboratory animals with its predecessor 86/609/EEC -A t4 report. ALTEX 27, 285-303. https://doi.org/10.14573/altex.2010.4.285.
29. Hartung, T. (2010d). Food for thought... on alternative methods for chemical safety testing. ALTEX 27, 3-14. https://doi.org/10.14573/altex.2010.1.3.
30. Hartung, T. and McBride, M. (2011). Food for thought... on mapping the human toxome. ALTEX 28, 83-93. https://doi.org/10.14573/altex.2011.2.083.
31. Hartung, T., van Vliet, E., Jaworska, J. et al. (2012). Systems toxicology. ALTEX 29, 119-128. https://doi.org/10.14573/altex.2012.2.119.
32. Hartung, T., Stephens, M. and Hoffmann, S. (2013a). Mechanistic validation. ALTEX 30, 119-130. https://doi.org/10.14573/altex.2013.2.119.
33. Hartung, T., Luechtefeld, T., Maertens, A. and Kleensang, A. (2013b). Integrated testing strategies for safety assessments. ALTEX 30, 3-18. https://doi.org/10.14573/altex.2013.1.003.
34. Hartung, T. (2016a). E-cigarettes and the need and opportunities for alternatives to animal testing. ALTEX 33, 211-224. https://doi.org/10.14573/altex.1606291.
35. Hartung, T. (2016b). Utility of the adverse outcome pathway concept in drug development. Expert Opin Drug Metabol Toxicol 13, 1-3. https://doi.org/10.1080/17425255.2017.1246535.
36. Hartung, T. (2017). Evolution of toxicological science: The need for change. Int J Risk Assess Manag, in press. http://www.inderscience.com/info/ingeneral/forthcoming.php?jcode=ijram.
37. Hoffmann, S. and Hartung, T. (2006). Towards an evidence-based toxicology. Hum Exp Toxicol 25, 497-513. https://doi.org/10.1191/0960327106het648oa.
38. Kleensang, A., Maertens, A., Rosenberg, M. et al. (2014). Pathways of toxicity. ALTEX 31, 53-61. https://doi.org/10.14573/altex.1309261.
39. Krewski, D., Acosta, D. Jr., Andersen, M. et al. (2010). Toxicity testing in the 21st century: A vision and a strategy. J Toxicol Environ Health, Part B, Crit Rev 13, 51-138. https://doi.org/10.1080/10937404.2010.483176.
40. Krewski, D., Westphal, M., Andersen, M. E. et al. (2014). A framework for the next generation of risk science. Environ Health Perspect 122, 796-805. https://doi.org/10.1289/ehp.1307260.
41. Leist, M., Hasiwa, N., Rovida, C. et al. (2014). Consensus report on the future of animal-free systemic toxicity testing. ALTEX 31, 341-356. https://doi.org/10.14573/altex.1406091.
42. Maertens, A., Luechtefeld, T., Kleensang, A. and Hartung, T. (2015). MPTP's pathway of toxicity indicates central role of transcription factor SP1. Arch Toxicol 89, 743-755. https://doi.org/10.1007/s00204-015-1509-6.
43. Maertens, A., Bouhifd, M., Zhao, L. et al. (2016). Metabolomic network analysis of estrogen-stimulated MCF-7 cells: A comparison of over-representation analysis, quantitative enrichment analysis and pathway analysis versus metabolite network analysis. Arch Toxicol 2017, in press. https://doi.org/10.1007/s00204-016-1695-x.
44. Marx, U., Andersson, T. B., Bahinski, A. et al. (2016). Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing using animals. ALTEX 33, 272-321. https://doi.org/10.14573/altex.1603161.
45. Moretto, A., Bachman, A., Boobis, A. et al. (2016). A framework for cumulative risk assessment in the 21st century. Crit Rev Toxicol, 1-13. https://doi.org/10.1080/10408444.2016.1211618.
46. NRC - National Research Council/National Academy of Sciences (2007). Toxicity Testing in the 21st Century: A Vision and a Strategy. https://doi.org/10.17226/11970.
47. Pamies, D. and Hartung, T. (2016). 21st century cell culture for 21st century toxicology. Chem Res Toxicol, in press. https://doi.org/10.1021/acs.chemrestox.6b00269.
48. Pamies, D., Bal-Price, A., Simeonov, A. et al. (2017). Good cell culture practice for stem cells and stem-cell-derived models. ALTEX 34, 95-132. https://doi.org/10.14573/altex.1607121.
49. Pastoor, T. P., Bachman, A. N., Bell, D. R. et al. (2014). A 21st century roadmap for human health risk assessment. Crit Rev Toxicol 44, Suppl 3, 1-5. https://doi.org/10.3109/10408444.2014.931923.
50. Patlewicz, G., Ball, N., Becker, R. A. et al. (2014). Read-Across approaches - misconceptions, promises and challenges ahead. ALTEX 31, 387-396. https://doi.org/10.14573/altex.1410071.
51. Patlewicz, G. and Fitzpatrick, J. M. (2016). Current and future perspectives on the development, evaluation, and application of in silico approaches for predicting toxicity. Chem Res Toxicol 29, 438-451. https://doi.org/10.1021/acs.chemrestox.5b00388.
52. Pendse, S. N., Maertens, A., Rosenberg, M. et al. (2016). Information-dependent enrichment analysis reveals time-dependent transcriptional regulation of the estrogen pathway of toxicity. Arch Toxicol, in press. https://doi.org/10.1101/038570.
53. Rappaport, S. M. (2011). Implications of the exposome for exposure science. J Expos Sci Environ Epidemiol 21, 5-9. https://doi.org/10.1038/jes.2010.50.
54. Richard, A. M., Judson, R. S., Houck, K. A. et al. (2016). Tox Cast chemical landscape: Paving the road to 21st century toxicology. Chem Res Toxicol 29, 1225-1251. https://doi.org/10.1021/acs.chemrestox.6b00135.
55. Rovida, C., Asakura, C., Daneshian, M. et al. (2015a). Toxicity testing in the 21st century beyond environmental chemicals. ALTEX 32, 25-40. https://doi.org/10.14573/altex.1411011.
56. Rovida, C., Alépée, N., Api, A. M. et al. (2015b). Integrated testing strategies (ITS) for safety assessment. ALTEX 32, 171-181. https://doi.org/10.14573/altex.1506201.
57. Samuel, G. O., Hoffmann, S., Wright, R. et al. (2016). Guidance on assessing the methodological and reporting quality of toxicologically relevant studies: A scoping review. Environ Int 92-93, 630-646. https://doi.org/10.1016/j.envint.2016.03.010.
58. Simon, T. W., Simons, S. S., Preston, R. J. et al. (2014). The use of mode of action information in risk assessment: Quantitative key events/dose-response framework for modeling the dose-response for key events. Crit Rev Toxicol 44, Suppl 3, 17-43. https://doi.org/10.3109/10408444.2014.931925.
59. Smith, M. T. and Rappaport, S. M. (2009). Building exposure biology centers to put the E into "G × E" interaction studies. Environ Health Perspect 117, A334-A335. https://doi.org/10.1289/ehp.12812.
60. Solomon, K. R., Wilks, M. F., Bachman, A. et al. (2016). Problem formulation for risk assessment of combined exposures to chemicals and other stressors in humans. Crit Rev Toxicol, 1-10. https://doi.org/10.1080/10408444.2016.1211617.
61. Stephens, M. L., Betts, K., Beck, N. B. et al. (2016). The emergence of systematic review in toxicology. Toxicol Sci 152, 10-16. https://doi.org/10.1093/toxsci/kfw059.
62. van Vliet, E., Daneshian, M., Beilmann, M. et al. (2014). Current approaches and future role of high content imaging in safety sciences and drug discovery. ALTEX 31, 479-493. https://doi.org/10.14573/altex.1405271.
63. Vineis, P., Chadeau-Hyam, M., Gmuender, H. et al. (2016). The exposome in practice: Design of the EXPOsOMICS project. Int J Hygiene Environ Health, in press. https://doi.org/10.1016/j.ijheh.2016.08.001.
64. Vrijheid, M., Slama, R., Robinson, O. et al. (2014). The human early-life exposome (HELIX): Project rationale and design. Environ Health Perspect 122, 535-544. https://doi.org/10.1289/ehp.1307204.
65. Wambaugh, J. F., Wetmore, B. A., Pearce, R. et al. (2015). Toxicokinetic triage for environmental chemicals. Toxicol Sci 147, 55-67. https://doi.org/10.1093/toxsci/kfv118.
66. Wetmore, B. A., Wambaugh, J. F., Allen, B. et al. (2015). Incorporating high-Throughput exposure predictions with dosimetry-Adjusted in vitro bioactivity to inform chemical toxicity testing. Toxicol Sci 148, 121-136. https://doi.org/10.1093/toxsci/kfv171.
67. Wild, C. P. (2005) Complementing the genome with an "exposome": The outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 14, 1847-1850. https://doi.org/10.1158/1055-9965.EPI-05-0456.
68. Zhu, H., Bouhifd, M., Kleinstreuer, N. et al. (2016). Supporting read-Across using biological data. ALTEX 33, 167-182. https://doi.org/10.14573/altex.1601252.
69. Zurlo, J. and Hutchinson, E. (2014). The state of animal welfare in the context of refinement. ALTEX 31, 4-10. https://doi.org/10.14573/altex.1312191.